Treatment
Medication clinical trials
We’re tracking 7,446 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT06896474Recruiting
Breast cancer treatment choice help for women 70 and older
This study tests a decision aid to help women 70 and older with early stage breast cancer choose their treatment. It looks at whether the tool helps patients and their doctors make a confident treatment choice.
Los Angeles, CaliforniaAges 18 years+ - NCT06896942Recruiting
Autism doula program for Black caregivers
This study offers a doula program (a trained support person) to help Black caregivers of young children newly diagnosed with autism. It aims to see if this support improves your experience and your child's development.
Cincinnati, OhioAges 1.5 years–5.9 years - NCT06896981RecruitingPhase 2/Phase 3
Semaglutide for women with PCOS and obesity
This study tests if a weekly injection called semaglutide can help women with PCOS and obesity lose weight and improve their health. It is for women who do not have other serious medical conditions.
Dhaka, Dhaka DivisionAges 10–45 - NCT06897046RecruitingPhase 2
Study of Iparomlimab and Tuvonralimab for resectable lung cancer
This trial tests two immunotherapy drugs (iparomlimab and tuvonralimab) before and after surgery for people with a certain type of lung cancer that can be removed. It aims to see if this treatment helps improve outcomes.
BeijingAges 18 years+ - NCT06897501Recruiting
Comparing breathing tubes for voice box protection during esophagectomy
This trial compares two types of breathing tubes used during robot-assisted esophageal cancer surgery. One tube blocks one lung (double-lumen tube) and the other tube uses a smaller blocker (bronchial blocker); researchers want to see which causes fewer voice box nerve injuries after surgery.
SeoulAges 19 years+ - NCT06897982Recruiting
Nutrition program for prediabetes at health center
This study tests a nutrition program for people with prediabetes at a health center. It aims to see if the program is practical and can help prevent type 2 diabetes.
Los Angeles, CaliforniaAges 18–99 - NCT06898216Recruiting
Comparing two tools for small kidney stones
This trial tests if a new steerable scope works better than a standard scope for removing small kidney stones (<2 cm) from the lower part of the kidney. It aims to find a safer and more effective way to treat these stones.
Guangzhou, GuangdongAges 18–75 - NCT06898437RecruitingEarly Phase 1
Lutetium-177 LNC1004 for advanced thyroid cancer that no longer responds to standard treatments
This trial tests a radioactive drug called 177Lu-LNC1004 for people with a type of thyroid cancer that is no longer responding to standard treatments. The drug targets a protein called FAP found on tumor cells, which may help shrink tumors and slow disease progression.
BeijingAges 18–85 - NCT06898593Recruiting
Including patient goals in collaborative care
This trial looks at ways to better include your personal goals and concerns in your care if you're already in the Collaborative Care Model at Dartmouth Health. It aims to make your treatment more focused on what matters to you.
Concord, New HampshireAges 18–100 - NCT06898723RecruitingPhase 4
Shenfu injection to prevent heart problems in sepsis
This trial tests whether Shenfu injection can help prevent heart muscle damage in people with septic shock. If you have septic shock, you may be able to join this study to see if this treatment helps protect your heart.
Wuhu, AnhuiAges 18 years+ - NCT06899152Recruiting
New tests to track liver health during radiation for liver cancer
This study tests new blood tests and MRI scans to see how well your liver works during radiation therapy for liver cancer. It may help doctors better plan treatment and monitor your liver health.
The Bronx, New YorkAges 18 years+ - NCT06899399Recruiting
Stent study for asymptomatic carotid artery blockage
This trial tests a stent procedure to open a severely blocked carotid artery in people who have not had a stroke or mini-stroke from that blockage recently. It aims to see if the procedure is safe and effective for preventing future strokes.
BeijingAges 40–80 - NCT06899750Recruiting
E3 Hypertension: A team program for blood pressure control
This study tests a team-based program to help African American and Latinx people with uncontrolled high blood pressure. You'll use a smartphone app and get extra support from a doctor team to manage your blood pressure better.
Chicago, IllinoisAges 18 years+ - NCT06899919Recruiting
Light compression wrap for mixed leg ulcers
This trial tests a light compression system for mixed leg ulcers, which are wounds on the lower leg that have both vein and artery problems. It may help you if you have this type of wound that is not too large or too old.
Paris, ParisAges 18 years+ - NCT06899997Recruiting
Alimentation limitée dans le temps pour les femmes obèses
Cette étude teste si limiter les heures de repas (par exemple, manger seulement entre 8h et 18h) améliore le système immunitaire des femmes obèses. Vous pourriez y participer si vous avez un IMC entre 40 et 50 ou un poids normal.
ParisAges 18–64 - NCT06901466RecruitingPhase 4
Blood thinner study after heart valve repair
This study tests different ways to use blood thinners after a minimally invasive heart valve repair procedure. It may help patients who need long-term blood thinning to prevent clots or stroke.
Beijing, Beijing MunicipalityAges Any age - NCT06902051Recruiting
Side-lying position for left breast cancer radiation
This trial tests whether lying on your right side during radiation therapy for left breast cancer can reduce side effects. It is for women who have had surgery for newly diagnosed left breast cancer and need radiation.
Guangzhou, Guangdong ProvinseAges 18–70 - NCT06902181Recruiting
Inhaling an essential oil for mild memory loss
This trial tests whether inhaling a special essential oil (CXMCI-01) can help people with mild cognitive impairment (MCI) — a condition where you have more memory problems than normal for your age. The study aims to see if the oil is safe and might improve memory and thinking.
TaichungAges 50 years+ - NCT06902740RecruitingPhase 4
PCSK9 inhibitor with statin for asymptomatic brain artery narrowing
This trial tests whether adding a PCSK9 inhibitor to standard statin therapy can help people with narrowing in brain arteries that hasn't caused symptoms yet. The goal is to see if this combination lowers plaque and prevents future strokes.
Beijing, Beijing MunicipalityAges 18–80 - NCT06902779Recruiting
Checking if hospital and pharmacy teamwork helps after discharge
This trial tests if better communication between hospital and community pharmacists after you leave the hospital can improve your care. It focuses on patients taking many medicines and going home directly.
Rennaz, Canton of VaudAges 18 years+ - NCT06903364Recruiting
Lifestyle and diabetes complications study
This study looks at how lifestyle habits affect complications in people with type 2 diabetes. It aims to understand what might help prevent or manage these issues.
GuangzhouAges 20 years+ - NCT06903845Recruiting
Apixaban study for atrial fibrillation
This trial tests whether apixaban, a blood thinner, works well for people with atrial fibrillation who also have heart or circulation conditions. It uses a smartphone app to help track your treatment.
Seongnam, GyeonggidoAges 19 years+ - NCT06903962Recruiting
Mind-body program for chronic arm or hand pain
This trial tests whether a mind-body program can help people with long-term pain in their upper arm, forearm, or hand that is not caused by a clear physical injury. It focuses on retraining how your brain responds to pain triggers.
Boston, MassachusettsAges 18–60 - NCT06904196RecruitingPhase 2
Lenvatinib with or without internal radiation for TACE-resistant liver cancer
This trial compares two treatments for liver cancer (HCC) that has stopped responding to TACE. One group gets lenvatinib (a targeted therapy pill) plus SIRT (internal radiation beads placed in the liver), and the other gets lenvatinib alone. The goal is to see which combination works better.
Guangzhou, GuangdongAges 18–75
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,446 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.